A proposed system for classifying psychotropic drugs

Area of Science:

• Psychiatry and Pharmacology
• Drug Classification Systems
• Neuroscience

Background:

• Current psychotropic drug classification relies on therapeutic indications, not pharmacological mechanisms.
• This approach limits a comprehensive understanding of drug actions and interactions.
• A need exists for a more precise and scientifically grounded classification method.

Purpose of the Study:

• To propose a novel multi-axial nomenclature system for psychotropic drugs.
• To reclassify existing medications and establish a framework for new drug compounds.
• To enhance the practical utility of drug information for healthcare professionals and patients.

Main Methods:

• Development of a five-axis classification system based on pharmacological profiles.
• Axis 1: Primary pharmacological target and mechanism.
• Axes 2-5: Neurotransmitter involvement, neurobiological activities, efficacy/side effects, and approved indications.

Main Results:

• A detailed description of the proposed five-axis classification system.
• The system integrates pharmacological, neurobiological, and clinical data.
• It provides a structured approach for categorizing diverse psychotropic agents.

Conclusions:

• The proposed multi-axial system offers a scientifically informed and practical method for classifying psychotropic drugs.
• This nomenclature facilitates a deeper understanding of drug mechanisms and clinical profiles.
• It is expected to benefit prescribers, clinicians, and patients by improving drug selection and management.